Pulmonary in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

... (Perforomist, DEY LP, Mylan Inc.) improves pulmonary function. "We are pleased that researchers ... formoterol fumarate significantly improved pulmonary function and was more satisfactory to COPD ... subjects provided significant improvements in pulmonary function, dyspnea, and rescue albuterol use over ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... time to clinical worsening in patients with pulmonary arterial hypertension (PAH)(1). The randomized, ... from the study entitled, "Tadalafil Therapy for pulmonary Arterial Hypertension," were published in today's ... at the University of Bologna and head of the pulmonary Hypertension Centre at the Institute of ...

AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA

... product comparable to standard insulin therapy in pulmonary function tests NEW ORLEANS, June 6 ... ultra rapid acting insulin with changes in pulmonary function tests comparable to usual antidiabetic ... Design and Key Findings Findings were based on pulmonary function tests (PFTs) over a 2-year period in ...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

... type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH). ADCIRCA is ... that constricts the flow of blood through the pulmonary vasculature. United Therapeutics licensed ... market, promote and commercialize ADCIRCA for pulmonary hypertension in the United States and Puerto Rico ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... lung vascular remodeling and the development of pulmonary hypertension was also demonstrated in an ATS ... as a new therapeutic for the treatment of pulmonary hypertension," stated Dr. Wolfgang M. Kuebler, ... aerosols, PARI Pharma develops treatments for pulmonary and nasal administration optimized with advanced ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented today in an oral ... in that country. About IPF Idiopathic pulmonary fibrosis (IPF) is a disabling and ultimately ... has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) ...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

... groups. We were pleased to see that serious pulmonary adverse events in the 900-mcg group were ... treatment group. Serious and/or severe pulmonary adverse events were infrequent and included the following: The rate of serious and/or severe pulmonary infections was comparable between the two groups, ...

Inverseon's Founder and SAB Member Published in PNAS

... F. Dickey, MD, Professor & Chair, Dept. of pulmonary Medicine, M.D. Anderson Cancer Center and ... needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hypertension. Inverseon was founded by EGB ...

Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis

... 4 /PRNewswire-USNewswire/ -- The Coalition for pulmonary Fibrosis (CPF) is calling this a historic time in ... may possibly be saved," Shreve said. About pulmonary Fibrosis (PF) pulmonary Fibrosis (PF) is a lung disorder characterized by ...

Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse

... Molecular Imaging technique for the diagnosis of pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ... to dominate the market for the diagnosis of pulmonary Embolism. In particular, this belief is driven ...

K-State Researcher Finds Correlation Between Childhood Obesity and Asthma

... For Rosenkranz's project, the children completed pulmonary function tests, an exercise test that doctors ... was sent to the parents that showed their child's pulmonary test results and body fat percentage, which also ... said. When considering childhood obesity, pulmonary function wasn't often considered, she said. ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... There were no reports of deep-vein thrombosis or pulmonary embolism. -- As initial therapy, all ... hypotension throughout therapy, cardiac and pulmonary disorders, reversible posterior ... been reports of acute diffuse infiltrative pulmonary disease of unknown etiology such as pneumonitis, ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... typically forms in a major vein of the leg, and pulmonary embolism, which occurs when a blood clot detaches ... limbs, visceral and cerebral venous thrombosis, pulmonary embolism, acute myocardial infarction, ischemic ... versus 3.2 percent) and fatal or non-fatal pulmonary embolism (1.6 percent versus 1.8 percent) were ...

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD

... with Moderate to Very Severe Chronic Obstructive pulmonary Disease [poster]. CHEST, Oct. 25-30, 2008, ... with Moderate to Very Severe Chronic Obstructive pulmonary Disease [poster]. CHEST, Oct. 25-30, ... with Moderate to Very Severe Chronic Obstructive pulmonary Disease [poster]. CHEST, Oct. 25-30, 2008, ...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

... in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Clinical results show that ... dosing and has anti-inflammatory properties in pulmonary tissues in addition and unrelated to its ... the effects seen on bacterial counts and pulmonary function give us confidence as we move MP-376 ...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

... study shows clinical improvement in patients with pulmonary arterial hypertension (PAH) -- Current ... results for imatinib mesylate in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable ... as demonstrated by a significant improvement in pulmonary vascular resistance and a numerical increase in ...

APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism

... the number of cases of deep vein thrombosis and pulmonary embolism in the United States. According to ... in Denver and member of APTA's Cardiovascular and pulmonary Section, blood clots, called deep vein thrombosis ... legs may dislodge and travel to the lungs, called pulmonary embolus. The symptoms of leg DVT include ...

MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes

... loss versus weight gain * No adverse effects on pulmonary function Dr. Peter Richardson, MannKind's Chief ... Insulin was generally well tolerated. No pulmonary neoplasms were reported. Consistent with the ... there were no between-group differences in pulmonary function measures, including FEV1 (forced ...

Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

... treatment of patients with chronic obstructive pulmonary disease (COPD). In both the ACCLAIM/COPD ... in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in moderate to severe ... WHO fact sheet 315. May 2008. Chronic obstructive pulmonary disease (COPD). ...

CryoCath Arctic Front(R) Results Published in JACC

... peer-reviewed article entitled, 'Circumferential pulmonary Vein Isolation with the Cryoballoon Technique', ... of persistent AFib patients (n=53). Of the 1,403 pulmonary veins treated, 1,360 (or 97 percent) were ablated ... of Arctic Front in effectively isolating the pulmonary veins, which is the clear strategy for ...

Pulmo BioTech Inc. Completes Bio-Distribution Studies

... for the diagnosis of Pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ... to dominate the market for the diagnosis of pulmonary Embolism. In particular, this belief is driven ... based technology for the diagnosis of pulmonary Embolism. In addition, early indications are that ...

Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting

... data on the CryoValve(R) SG decellularized pulmonary human heart valve were presented on June 28th ... who received a conventionally processed CryoValve pulmonary heart valve. All patients received the valves in ... underlying collagen matrix. The CryoValve SG pulmonary human heart valve is indicated for ...

Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

... 2 clinical study with MP-376 for the treatment of pulmonary infections due to Pseudomonas aeruginosa ... Pseudomonas aeruginosa. Chronic pulmonary infection is associated with a decrease in lung ... administration of systemic antibiotics. Chronic pulmonary infections and associated exacerbations ...

Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times

... Weber reported success in isolating 98 percent of pulmonary veins with a remarkably short average ablation ... (RF) energy needed to successfully isolate the pulmonary veins was 22.4 +/- 2.9 minutes. "We found that mapping and ablation of the pulmonary veins using a single catheter, without 3D ...

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

... to WHO FC III/IV. A significant reduction in pulmonary vascular resistance and a positive trend in ... patient outcome. Notes to editor About pulmonary Arterial Hypertension (PAH) PAH is a syndrome ... Class II patients are defined as patients with pulmonary hypertension resulting in mild limitation of ...

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration

... seven presentations concerning the treatment of pulmonary arterial hypertension (PAH) with ... PAH, Dr. Vallerie McLaughlin, Director of the pulmonary Hypertension Program at the University of ... pm EDT. Vallerie McLaughlin, MD, Director of the pulmonary Hypertension Program at the University of ...

Amikacin Inhale Shows Promising Results in Phase II Study

... with Nektar Therapeutics' proprietary Liquid pulmonary Technology (LPT(TM)), designed to deliver ... on Day 3. Clinical parameters, such as Clinical pulmonary Infection Score (CPIS), days on ventilator and ... with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and ...

Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials

... Molecular Imaging technology for the diagnosis of pulmonary Embolism and Pulmonary Hypertension. The work ... the Use of PulmoBind for Molecular Imaging of the pulmonary Circulation." The study will be a single ... for the diagnosis of Pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ...

Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society

... at 5:00 pm EDT. Lewis Rubin, MD, Director of the pulmonary Hypertension Program at the University ... company focused on unmet medical needs in pulmonary medicine and pulmonary delivery of innovative therapeutic products. ...

PulmoBioTech Announces Details of Its Regulatory Approval Experiments

... for the diagnosis of Pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ... to dominate the market for the diagnosis of pulmonary Embolism. In particular, this belief is driven ... based technology for the diagnosis of pulmonary Embolism. In addition, early indications are that ...

InterMune Announces Progress on Pirfenidone in IPF

... safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF). The roll-over study will be ... Trial of Pirfenidone in Patients with Idiopathic pulmonary Fibrosis in Japan" [Session C95], is now posted ... . About IPF Idiopathic pulmonary fibrosis (IPF) is a disabling and ultimately ...

Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve

... the valve between the right ventricle and the pulmonary artery is nonfunctional. "We were able to ... to symptomatic patients with a failing pulmonary valve conduit, giving them the opportunity to ... delivery system and deployed across the patient's pulmonary valve. The valve replacement is accomplished as a ...

MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics

... treatment of asthma and chronic obstructive pulmonary disease (COPD). MAP0005 is a single-particle ... with combination therapy. Chronic obstructive pulmonary disease refers to several diseases, including ... the treatment of asthma and chronic obstructive pulmonary disease. Additional information about MAP ...

Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs

... study for TPI 1020 in Chronic Obstructive pulmonary Disease (COPD), following promising top-line ... 1020 (formerly NCX 1020) in Chronic Obstructive pulmonary Disease (COPD). This study is expected to provide ... hypertension, glaucoma and Chronic Obstructive pulmonary Disease (COPD). NicOx S.A. is headquartered in ...

ImaRx Therapeutics Transitions Business Strategy

... indicated for the treatment of acute massive pulmonary embolism, or blood clots in the lungs. ... urokinase, for the treatment of acute massive pulmonary embolism. The Company's research and development ... indicated for the treatment of acute massive pulmonary embolism, or blood clots in the lungs. The ...

Inverseon Announces Positive Phase IIa Asthma Study

... in asthma. In the article by Hanania et al., in pulmonary Pharmacology & Therapeutics, vol. 21, (2008), pp. ... needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hypertension. Inverseon was founded based on the ...

Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1

... Robert A. Sandhaus, MD, PhD, of the Division of pulmonary Medicine, National Jewish Medical and Research ... been diagnosed with COPD (Chronic Obstructive pulmonary Disease), an umbrella term that includes ... therapists to perform significant pulmonary clinical research. "Respiratory therapists will ...

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

... for people with cystic fibrosis (CF) who have pulmonary Pseudomonas aeruginosa (P. aeruginosa) ... which continually damage their lungs. pulmonary infection with Gram-negative bacteria, ... aerosols, PARI Pharma develops treatments for pulmonary and nasal administration optimized to advanced ...

NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020

... concept study for TPI 1020 in Chronic Obstructive pulmonary Disease (COPD) - see TOPIGEN press release ... in patients suffering from chronic obstructive pulmonary disease (COPD). TPI 1020 is a ... respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. TOPIGEN is actively ...

Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension

... as a combination therapy for the treatment of pulmonary arterial hypertension (PAH). Data from ... and mortality in symptomatic PAtientS with pulmonary arterial hypertenSion) was the first clinical ... patients as a monotherapy. About Tracleer(R) in pulmonary Arterial Hypertension (PAH) Tracleer(R) ...